Does Rallies show 13F holders for HNGE?

Yes. Rallies tracks hedge fund and 13F ownership data for HNGE, including fund names, share counts, latest tracked quarter, and position changes when available.

Is HNGE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HNGE. It does not provide personalized investment advice.

HNGE (Hinge Health, Inc.) Stock Analysis - Hedge Fund Holdings

Hinge Health, Inc. (HNGE) is a publicly traded Healthcare sector company. As of May 21, 2026, HNGE trades at $55.84 with a market cap of $4.23B and a P/E ratio of -5.08. HNGE moved -0.64% today. Year to date, HNGE is +16.77%; over the trailing twelve months it is flat. Its 52-week range spans $30.08 to $62.18. Analyst consensus is strong buy with an average price target of $68.15. Rallies surfaces HNGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns HNGE stock?

Hedge funds tracked by Rallies that own HNGE include Coatue Management, Tiger Global, Redmile Group, Whale Rock, and Soros Fund. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Hinge Health, Inc..

HNGE Key Metrics

Key financial metrics for HNGE
Metric	Value
Price	$55.84
Market Cap	$4.23B
P/E Ratio	-5.08
EPS	$-10.58
Dividend Yield	0.00%
52-Week High	$62.18
52-Week Low	$30.08
Volume	568
Avg Volume	0
Revenue (TTM)	$646.34M
Net Income	$-510.27M
Gross Margin	80.80%

Top Hedge Funds Holding HNGE

Coatue Management holds 4.70M shares of HNGE, changed +0.00% as of Sep 30, 2025.
Tiger Global holds 1.81M shares of HNGE, changed +227.12% as of Dec 31, 2025.
Redmile Group holds 300.00K shares of HNGE, changed +0.00% as of Jun 30, 2025.
Whale Rock holds 173.54K shares of HNGE, changed +0.00% as of Sep 30, 2025.
Soros Fund holds 78.56K shares of HNGE, changed +4.75% as of Sep 30, 2025.

Latest HNGE News

Analysts See 39% Upside in Hinge Health as EPS Estimates Climb 63% — Feb 20, 2026
Hinge Health Jumps 17% on 50.7% Revenue Growth and 25% 2026 Guidance — Feb 12, 2026
Hinge Health Report Finds Treatment Gaps in 1,000-Patient MSK Study — Jan 15, 2026

Recent HNGE Insider Trades

Budge James sold 4.71K (~$257.19K) on May 11, 2026.
Budge James sold 1.20K (~$66.57K) on May 11, 2026.
Perez Daniel Antonio sold 45.46K (~$2.50M) on May 7, 2026.

HNGE Analyst Consensus

13 analysts cover HNGE: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $68.15.

Common questions about HNGE

Who owns HNGE stock?: Hedge funds tracked by Rallies that own HNGE include Coatue Management, Tiger Global, Redmile Group, Whale Rock, and Soros Fund. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Hinge Health, Inc..
Does Rallies show 13F holders for HNGE?: Yes. Rallies tracks hedge fund and 13F ownership data for HNGE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HNGE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HNGE. It does not provide personalized investment advice.